Clinical Trials Browser

Recruiting × gemcitabine-oxaliplatin regimen × Gastrointestinal × Clear all

NCT06505486 2024-07-17

GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC

Gastrointestinal

Cholangiocarcinoma